Similar articles for PMID: 21609991

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
1993	3
1997	1
1998	1
1999	2
2000	1
2001	2
2002	2
2003	7
2004	5
2005	4
2006	7
2007	4
2008	5
2009	8
2010	3
2011	4
2012	5
2013	6
2014	2
2015	4
2016	8
2017	11
2018	8
2019	2
2020	3
2021	5
2022	2
2024	0

Results by year

Page 1

SaskPharm: a proposal for provincial drug production.

Meili R. Meili R. CMAJ. 2011 Jul 12;183(10):1224. doi: 10.1503/cmaj.101814. Epub 2011 May 24. CMAJ. 2011. PMID: 21609991 Free PMC article. No abstract available.

Competition watchdog finds new target: overpriced generics.

Hawkes N. Hawkes N. BMJ. 2016 Dec 14;355:i6712. doi: 10.1136/bmj.i6712. BMJ. 2016. PMID: 27974337 No abstract available.

Angst about exclusivity: The potential cost of incentivizing makers of generic drugs.

Chakradhar S, Khamsi R. Chakradhar S, et al. Nat Med. 2017 Oct 6;23(10):1114-1116. doi: 10.1038/nm1017-1114. Nat Med. 2017. PMID: 28985215 No abstract available.

In that case: a pharmaceutical company that makes generic versions of commonly used drugs has produced a generic of a proprietary drug widely prescribed in a particular service. Response.

Woolner D. Woolner D. N Z Bioeth J. 2003 Oct;4(3):22, 25-6. N Z Bioeth J. 2003. PMID: 15597481 No abstract available.

Brand-name versus generic.

Copeland KR, Boccuzzi SJ. Copeland KR, et al. Health Aff (Millwood). 2007 Jul-Aug;26(4):1198-9; author reply 1199. doi: 10.1377/hlthaff.26.4.1198-a. Health Aff (Millwood). 2007. PMID: 17630468 No abstract available.

Expensive Medicine: Drug prices are increasingly hard to swallow. Effective remedies prove elusive.

Bell H. Bell H. Minn Med. 2017 May;100(3):10-17. Minn Med. 2017. PMID: 30452131

The new drug war.

Sherrid P. Sherrid P. US News World Rep. 2002 Dec 2;133(21):41. US News World Rep. 2002. PMID: 12503485 No abstract available.

Antitrust, Market Exclusivity, and Transparency in the Pharmaceutical Industry.

Sinha MS, Curfman GD, Carrier MA. Sinha MS, et al. JAMA. 2018 Jun 12;319(22):2271-2272. doi: 10.1001/jama.2018.3478. JAMA. 2018. PMID: 29801104 No abstract available.

In that case: a pharmaceutical company that makes generic versions of commonly used drugs has produced a generic of a proprietary drug widely prescribed in a particular service. Response.

Menkes DB, Woodall AA. Menkes DB, et al. N Z Bioeth J. 2003 Oct;4(3):22, 24-5. N Z Bioeth J. 2003. PMID: 15597480 No abstract available.

Selling Patents to Indian Tribes to Delay the Market Entry of Generic Drugs.

Ablavsky G, Larrimore Ouellette L. Ablavsky G, et al. JAMA Intern Med. 2018 Feb 1;178(2):179-180. doi: 10.1001/jamainternmed.2017.7463. JAMA Intern Med. 2018. PMID: 29297039 Review. No abstract available.

108 results

Page of 11

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

108 results

Results by year